Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions

Journal of Pharmaceutical Sciences

Volumn 96, Issue 12, 2007, Pages 3196-3213

  Yang, Tianzhi ^a   Roder, Karen E ^a   Abbruscato, Thomas J ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

bEnd5 cells; Blood brain barrier; Bovine brain microvessel endothelial cells; Cell culture; in vitro models; Passive diffusion transport; Stroke; Tight junction

Indexed keywords

CLAUDIN 1; GLUCOSE TRANSPORTER 1; GLYCOPROTEIN P; OCCLUDIN; PROPRANOLOL; PROTEIN KINASE C; PROTEIN ZO1; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SUCROSE; UVOMORULIN;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRIC RESISTANCE; GLUCOSE BLOOD LEVEL; HYPOXIA; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; REOXYGENATION; SPINDLE CELL; STROKE; WESTERN BLOTTING;

EID: 38149139373     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21002     Document Type: Article

References (49)

1. Abbruscato TJ, Davis TP. 1999. Combination of hypoxia/aglycemia compromises in vitro BBB integrity. J Pharmacol Exp Ther 289:668-675.
2. Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT. 1990. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 7:435-451.
3. Audus KL, Borchardt RT. 1987. Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann NY Acad Sci 507:9-18.
4. Abbruscato TJ, Davis TP. 1999. Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: Influence of astrocyte contact. Brain Res 842:277-286.
5. Abbruscato TJ, Lopez SP, Mark KS, Hawkins BT, Davis TP. 2002. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 91:2525-2538.
6. Brownson EA, Abbruscato TJ, Gillespie TJ, Hruby VJ, Davis TP. 1994. Effect of peptidases at the blood-brain barrier on the permeability of enkephalin. J Pharmacol Exp Ther 270:675-680.
7. Abbruscato TJ, Lopez SP, Roder K, Paulson JR. 2004. Regulation of blood-brain barrier Na,K,2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. J Pharmacol Exp Ther 310:459-468.
8. Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. 2006. Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure. Pharm Res 23:291-302.
9. Gumbleton M, Audus KL. 2001. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci 90:1681-1698.
10. Otis KW, Avery ML, Broward-Partin SM, Hansen DK, Behlow HW Jr, Scott DO, Thompson TN. 2001. Evaluation of the BBMEC model for screening the CNS permeability of drugs. J Pharmacol Toxicol Methods 45:71-77.
11. Yang J, Aschner M. 2003. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport. Neurotoxicology 24:741-774.
12. Franke H, Galla H, Beuckmann CT. 2000. Primary cultures of brain microvessel endothelial cells: A valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Protoc 5:248-256.
13. Wang Q, Rager JD, Weinstein K, Kardos PS, Dobson GL, Li J, Hidalgo IJ. 2005. Evaluation of the MDR-MDCK cell line as permeability careen for the blood-brain barrier. Int J Pharm 288:349-359.
14. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. 2005. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res 1064:21-31.
15. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M. 2003. Evaluation of the immortalized mouse brain capillary endothelial cell line, b.End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 990:95-112.
16. Brown RC, Morris AP, O'neil RG. 2007. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130:17-30.
17. Williams RL, Risau W, Zerwes HG, Drexler H, Aguzzi A, Wagner EF. 1989. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 57:1053-1063.
18. Wagner EF, Risau W. 1994. Oncogenes in the study of endothelial cell growth and differentiation. Semin Cancer Biol 5:137-145.
19. Rohnelt RK, Hoch G, Reiss Y, Engelhardt B. 1997. Immunosurveillance modeled in vitro: Naive and memory T cells spontaneously migrate across unstimulated microvascular endothelium. Int Immunol 9:435-150.
20. Pruett SB, Obiri N, Kiel JL. 1989. Involvement relative importance of at least two distinct mechanisms in the effects of 2-mercaptoethanol on murine lymphocytes in culture. J Cell Physiol 141:40-45.
21. Raub TJ, Kuentzel SL, Sawada GA. 1992. Permeability of bovine brain microvessel endothelial cells in vitro: Barrier tightening by a factor released from astroglioma cell. Exp Cell Res 199:330-340.
22. Mark KS, Davis TP. 2002. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol 282:H1485-H1494.
23. Weber SJ, Abbruscato TJ, Brownson EA, Lipkowski AW, Plot R, Misicka A, Haaseth RC, Bartosz H, Hruby VJ, Davis TP. 1993. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J Pharmacol Exp Ther 266:1649-1655.
24. Sun H, Dai H, Shaik N, Elmquist WF. 2003. Drug efflux transporters in the CNS. Adv Drug Deliv Rev 55:83-105.
25. Schinkel AH, Wagenaar E, Mol CA, Vandeemter L. 1996. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97:2517-2524.
26. Payne JA, Rivera C, Viopio J, Kaila K. 2003. Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 26:199-206.
27. 2+ signaling in astrocytes in an in vitro ischemic model. J Neurosci 24:9585-9597.
28. McEwen BS, Reagan LP. 2004. Glucose tranporter expression in the central nervous system: Relationship to synaptic function. Eur J Pharmacol 490:13-24.
29. Giaume C, Tabernero A, Medina JM. 1997. Metabolic trafficking through astrocytic gap junctions. Glia 21:114-123.
30. Nishizaki T, Matsuoka T. 1998. Low glucose enhances Na+/glucose transport in bovine brain artery endothelial cells. Stroke 29:844-849.
31. Elfeber K, Kohler A, Lutzenburg M, Osswald C, Galla HJ, Witte OW, Koepsell H. 2004. Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol 121:201-207.
32. Wieloch T, Cardell M, Bingren H, Zivin J, Saitoh T. 1991. Changes in the activity of protein kinase C and the differential subcellular redistribution of its isozymes in the rat striatum during and following transient forebrain ischemia. J Neurochem 56:1227-1235.
33. Boveri M, Berezowski V, Price A, Slupek S, Lenfant A, Benaud C, Hartung T, Cecchelli R, Prieto P, Dehouck M. 2005. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51:187-198.
34. Tan KH, Dobbie MS, Felix RA, Barrand MA, Hurst RD. 2001. A comparison of the induction of immortalized endothelial cell impermeability by astrocytes. NeuroReport 12:1329-1334.
35. Gaillard PJ, Voorwinden LH, Nielsen JL, Ivanov A, Atsumin R, Engman H, Ringbom C, de Boer AG, Breimer DD. 2001. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 12:215-222.
36. Hatashita S, Hoff JT. 1990. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke 21:582-588.
37. Hirano A, Kawanami T, Llena J. 1994. Electron microscopy of the blood-brain barrier in disease. Microsc Res Tech 27:543-556.
38. Yang G, Betz AL. 1994. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658-1664.
39. Wolburg H, Neuhaus J, Kniesel U, Krauss B, Schimid EM, Ocalan M, Farrell C, Risau W. 1994. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci 107:1347-1357.
40. Reese TS, Karnovsky MJ. 1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J cell Biol 34:207-217.
41. Hayashi K, Nakao S, Nakaoke R, Nakagawa S, Kitagawa N, Niwa M. 2004. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul Pept 123:77-83.
42. Dimova S, Brewster ME, Noppe M, Jorissen M, Augustijins P. 2005. The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro 19:107-122.
43. Pal D, Audus KL, Siahaan TJ. 1997. Modulation of cellular adhesion in bovine brain microvessel endothelial cells by a decapeptide. Brain Res 747:103-113.
44. Abbott NJ, Revest PA. 1991. Control of brain endothelial permeability. Cerebrovasc Brain Metab Rev 3:39-72.
45. Rubin LL, Staddon JM. 1999. The cell biology of the blood-brain barrier. Ann Rev Neurosci 22:11-28.
46. Cornford EM. 1985. The blood-brain barrier, a dynamic regulatory interface. Mol Physiol 7:219-259.
47. Nishizuka Y. 1992. Interacellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
48. Krizbai IA, Deli MA. 2003. Signaling pathways regulation the tight junction permeability in the blood-brain barrier. Cell Mol Biol 49:23-31.
49. Fleegal MA, Hom S, Borg LK, Davis TP. 2005. Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol 289:H2012-H2019.